Deborah B. Leiderman, MD

Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.

Uniformed Services University Of The Health Sciences F. Edward Hébert School Of Medicine - Bethesda MD
Rank: Assistant Professor
Years: 1990-1993

University Of Michigan Medical School - Ann Arbor MI
Rank: Adjunct Clinical Associate Professor
Years: 1994-1995

Uniformed Services University Of The Health Sciences F. Edward Hébert School Of Medicine - Bethesda MD
Rank: Adjunct Associate Professor
Years: 1996-2004

VA Hospital Ann Arbor
Rank: Attending
Years: 1994-1995
VA Hospital Washington, D.C.
Rank: Consultant, Specialist
Years: 1996-1999
VA Hospital Washington DC
Rank: Instructor
Years: 2008-2010

A placebo-controlled trial of gabapentin in Amyotrophic lateral sclerosis
Neurology
46(2): A469
Date: 04 1996

Effect of seizures on cerebral blood flow measured with O15-H2O and positron emission tomotraphy
Epilepsia
37(8): 796-802
Date: 07 1996

Gabapentin in generalized seizures
Epilepsy Research
25(3): 191-197
Date: 11 1996

Gabapentin monotherapy: I. An 8 day, double -blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures
Neurology
49 (3):739-45
Date: 09 1997

Plans, designs, and analyses for clinical trials of anti-cocaine medications: where we are today
J. Clin Psychopharmacology
19 (3): 246-56
Date: 06 1999

Risk Management of drug products and the US Food and Drug Administration
Drug and Alcohol Dependence
105; S9-13
Date: 12 2009

Reserach Design considerations for clnical studies of abuse-deterrent opioid anagesics: IMMPACT recommendations
Pain
153 (10): 1997-2008
Date: 10 2012

Core Outcome Measure for opioid abuse liability laboratory assessment studies in humans: IMMPACT recommendations
Pain
153 (12): 2315-24
Date: 12 2012

Abuse Libility measures for use in analgesic clinical trials in patients with pain: IMMPACT recommendations
Pain
154 (11) :2324-34
Date: 11 2013